United Therapeutics buy Royal Bank of Canada
Start price
26.02.26
/
50%
€426.90
Target price
26.02.27
€544.04
Performance (%)
13.89%
Price
28.04.26
€486.20
Summary
This prediction is currently active. The prediction currently has a performance of 13.89%. This prediction currently runs until 26.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -0.634% | -0.634% |
| iShares Core DAX® | -1.499% | 7.705% |
| iShares Nasdaq 100 | 1.380% | 16.275% |
| iShares Nikkei 225® | -1.992% | 13.113% |
| iShares S&P 500 | 0.345% | 10.816% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (UTHR) had its price target raised by Royal Bank Of Canada from $587.00 to $643.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€364.40
26.09.25
26.09.25
€487.63
26.09.26
26.09.26
33.42%
28.04.26
28.04.26
